HEADER TRANSCRIPTION 18-JUL-11 3SZ1 TITLE HUMAN PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH LUTEOLIN AND TITLE 2 MYRISTIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: PPAR-GAMMA, NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARG, NR1C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS PPAR GAMMA, NUCLEAR RECEPTOR, LUTEOLIN, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR A.C.PUHL,A.BERNARDES,I.POLIKARPOV REVDAT 3 28-FEB-24 3SZ1 1 REMARK SEQADV REVDAT 2 19-JUN-13 3SZ1 1 JRNL REVDAT 1 21-MAR-12 3SZ1 0 JRNL AUTH A.C.PUHL,A.BERNARDES,R.L.SILVEIRA,J.YUAN,J.L.CAMPOS, JRNL AUTH 2 D.M.SAIDEMBERG,M.S.PALMA,A.CVORO,S.D.AYERS,P.WEBB, JRNL AUTH 3 P.S.REINACH,M.S.SKAF,I.POLIKARPOV JRNL TITL MODE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA JRNL TITL 2 ACTIVATION BY LUTEOLIN. JRNL REF MOL.PHARMACOL. V. 81 788 2012 JRNL REFN ISSN 0026-895X JRNL PMID 22391103 JRNL DOI 10.1124/MOL.111.076216 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.5_2 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.03 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.010 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 3 NUMBER OF REFLECTIONS : 27727 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 1416 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 30.0306 - 4.9486 1.00 2868 164 0.2029 0.2104 REMARK 3 2 4.9486 - 3.9306 0.99 2778 174 0.1733 0.1885 REMARK 3 3 3.9306 - 3.4346 0.99 2799 124 0.1835 0.1898 REMARK 3 4 3.4346 - 3.1209 0.97 2748 127 0.2128 0.2802 REMARK 3 5 3.1209 - 2.8974 0.96 2690 137 0.2372 0.2999 REMARK 3 6 2.8974 - 2.7267 0.95 2646 143 0.2210 0.2467 REMARK 3 7 2.7267 - 2.5902 0.92 2558 132 0.2353 0.2773 REMARK 3 8 2.5902 - 2.4775 0.89 2443 158 0.2412 0.3186 REMARK 3 9 2.4775 - 2.3822 0.87 2452 124 0.2431 0.3487 REMARK 3 10 2.3822 - 2.3000 0.84 2329 133 0.2622 0.3016 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.35 REMARK 3 B_SOL : 62.06 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.360 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.57500 REMARK 3 B22 (A**2) : 14.15180 REMARK 3 B33 (A**2) : -10.57680 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 12.41690 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.018 4244 REMARK 3 ANGLE : 1.637 5737 REMARK 3 CHIRALITY : 0.100 672 REMARK 3 PLANARITY : 0.008 730 REMARK 3 DIHEDRAL : 19.778 1587 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3SZ1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-JUL-11. REMARK 100 THE DEPOSITION ID IS D_1000066829. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-JUL-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : LNLS REMARK 200 BEAMLINE : W01B-MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.4586 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.15 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29570 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 116.668 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.700 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07900 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.10 REMARK 200 R MERGE FOR SHELL (I) : 0.47400 REMARK 200 R SYM FOR SHELL (I) : 0.47400 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM CITRATE 0.90 M, HEPES 0.1 M, PH REMARK 280 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 46.13000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.07500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 46.13000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 31.07500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 200 REMARK 465 SER A 201 REMARK 465 HIS A 202 REMARK 465 MET A 203 REMARK 465 LEU A 204 REMARK 465 ASN A 205 REMARK 465 PRO A 206 REMARK 465 LYS A 263 REMARK 465 PHE A 264 REMARK 465 LYS A 265 REMARK 465 HIS A 266 REMARK 465 ILE A 267 REMARK 465 THR A 268 REMARK 465 PRO A 269 REMARK 465 LEU A 270 REMARK 465 GLN A 271 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 SER A 274 REMARK 465 TYR A 477 REMARK 465 GLY B 200 REMARK 465 SER B 201 REMARK 465 HIS B 202 REMARK 465 MET B 203 REMARK 465 LEU B 204 REMARK 465 ASN B 205 REMARK 465 PRO B 206 REMARK 465 THR B 241 REMARK 465 THR B 242 REMARK 465 ASP B 243 REMARK 465 LYS B 244 REMARK 465 PRO B 269 REMARK 465 LEU B 270 REMARK 465 GLN B 271 REMARK 465 GLU B 272 REMARK 465 GLN B 273 REMARK 465 SER B 274 REMARK 465 MET B 463 REMARK 465 SER B 464 REMARK 465 TYR B 477 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 216 CE NZ REMARK 470 LYS A 240 CG CD CE NZ REMARK 470 LYS A 244 CG CD CE NZ REMARK 470 MET A 257 CG SD CE REMARK 470 ASP A 260 CG OD1 OD2 REMARK 470 LYS A 261 CG CD CE NZ REMARK 470 LYS A 275 CG CD CE NZ REMARK 470 GLU A 343 CG CD OE1 OE2 REMARK 470 LYS A 358 CE NZ REMARK 470 LYS A 434 CE NZ REMARK 470 GLN A 444 CG CD OE1 NE2 REMARK 470 LYS A 457 CG CD CE NZ REMARK 470 LYS A 474 CG CD CE NZ REMARK 470 LYS B 224 CE NZ REMARK 470 LYS B 232 CD CE NZ REMARK 470 LYS B 240 CG CD CE NZ REMARK 470 LYS B 261 CG CD CE NZ REMARK 470 LYS B 263 CG CD CE NZ REMARK 470 LYS B 275 CG CD CE NZ REMARK 470 GLN B 283 CG CD OE1 NE2 REMARK 470 LYS B 319 CE NZ REMARK 470 LYS B 358 CE NZ REMARK 470 LYS B 373 NZ REMARK 470 LYS B 422 CG CD CE NZ REMARK 470 LYS B 457 CG CD CE NZ REMARK 470 LYS B 458 CD CE NZ REMARK 470 LEU B 476 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OG1 THR A 229 OG1 THR A 241 2555 2.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 460 75.11 -105.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE KNA A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE KNA A 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LU2 B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MYR B 478 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3OM9 RELATED DB: PDB REMARK 900 RELATED ID: 1PRG RELATED DB: PDB REMARK 900 RELATED ID: 3PBA RELATED DB: PDB DBREF 3SZ1 A 204 477 UNP P37231 PPARG_HUMAN 232 505 DBREF 3SZ1 B 204 477 UNP P37231 PPARG_HUMAN 232 505 SEQADV 3SZ1 GLY A 200 UNP P37231 EXPRESSION TAG SEQADV 3SZ1 SER A 201 UNP P37231 EXPRESSION TAG SEQADV 3SZ1 HIS A 202 UNP P37231 EXPRESSION TAG SEQADV 3SZ1 MET A 203 UNP P37231 EXPRESSION TAG SEQADV 3SZ1 GLY B 200 UNP P37231 EXPRESSION TAG SEQADV 3SZ1 SER B 201 UNP P37231 EXPRESSION TAG SEQADV 3SZ1 HIS B 202 UNP P37231 EXPRESSION TAG SEQADV 3SZ1 MET B 203 UNP P37231 EXPRESSION TAG SEQRES 1 A 278 GLY SER HIS MET LEU ASN PRO GLU SER ALA ASP LEU ARG SEQRES 2 A 278 ALA LEU ALA LYS HIS LEU TYR ASP SER TYR ILE LYS SER SEQRES 3 A 278 PHE PRO LEU THR LYS ALA LYS ALA ARG ALA ILE LEU THR SEQRES 4 A 278 GLY LYS THR THR ASP LYS SER PRO PHE VAL ILE TYR ASP SEQRES 5 A 278 MET ASN SER LEU MET MET GLY GLU ASP LYS ILE LYS PHE SEQRES 6 A 278 LYS HIS ILE THR PRO LEU GLN GLU GLN SER LYS GLU VAL SEQRES 7 A 278 ALA ILE ARG ILE PHE GLN GLY CYS GLN PHE ARG SER VAL SEQRES 8 A 278 GLU ALA VAL GLN GLU ILE THR GLU TYR ALA LYS SER ILE SEQRES 9 A 278 PRO GLY PHE VAL ASN LEU ASP LEU ASN ASP GLN VAL THR SEQRES 10 A 278 LEU LEU LYS TYR GLY VAL HIS GLU ILE ILE TYR THR MET SEQRES 11 A 278 LEU ALA SER LEU MET ASN LYS ASP GLY VAL LEU ILE SER SEQRES 12 A 278 GLU GLY GLN GLY PHE MET THR ARG GLU PHE LEU LYS SER SEQRES 13 A 278 LEU ARG LYS PRO PHE GLY ASP PHE MET GLU PRO LYS PHE SEQRES 14 A 278 GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SEQRES 15 A 278 SER ASP LEU ALA ILE PHE ILE ALA VAL ILE ILE LEU SER SEQRES 16 A 278 GLY ASP ARG PRO GLY LEU LEU ASN VAL LYS PRO ILE GLU SEQRES 17 A 278 ASP ILE GLN ASP ASN LEU LEU GLN ALA LEU GLU LEU GLN SEQRES 18 A 278 LEU LYS LEU ASN HIS PRO GLU SER SER GLN LEU PHE ALA SEQRES 19 A 278 LYS LEU LEU GLN LYS MET THR ASP LEU ARG GLN ILE VAL SEQRES 20 A 278 THR GLU HIS VAL GLN LEU LEU GLN VAL ILE LYS LYS THR SEQRES 21 A 278 GLU THR ASP MET SER LEU HIS PRO LEU LEU GLN GLU ILE SEQRES 22 A 278 TYR LYS ASP LEU TYR SEQRES 1 B 278 GLY SER HIS MET LEU ASN PRO GLU SER ALA ASP LEU ARG SEQRES 2 B 278 ALA LEU ALA LYS HIS LEU TYR ASP SER TYR ILE LYS SER SEQRES 3 B 278 PHE PRO LEU THR LYS ALA LYS ALA ARG ALA ILE LEU THR SEQRES 4 B 278 GLY LYS THR THR ASP LYS SER PRO PHE VAL ILE TYR ASP SEQRES 5 B 278 MET ASN SER LEU MET MET GLY GLU ASP LYS ILE LYS PHE SEQRES 6 B 278 LYS HIS ILE THR PRO LEU GLN GLU GLN SER LYS GLU VAL SEQRES 7 B 278 ALA ILE ARG ILE PHE GLN GLY CYS GLN PHE ARG SER VAL SEQRES 8 B 278 GLU ALA VAL GLN GLU ILE THR GLU TYR ALA LYS SER ILE SEQRES 9 B 278 PRO GLY PHE VAL ASN LEU ASP LEU ASN ASP GLN VAL THR SEQRES 10 B 278 LEU LEU LYS TYR GLY VAL HIS GLU ILE ILE TYR THR MET SEQRES 11 B 278 LEU ALA SER LEU MET ASN LYS ASP GLY VAL LEU ILE SER SEQRES 12 B 278 GLU GLY GLN GLY PHE MET THR ARG GLU PHE LEU LYS SER SEQRES 13 B 278 LEU ARG LYS PRO PHE GLY ASP PHE MET GLU PRO LYS PHE SEQRES 14 B 278 GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SEQRES 15 B 278 SER ASP LEU ALA ILE PHE ILE ALA VAL ILE ILE LEU SER SEQRES 16 B 278 GLY ASP ARG PRO GLY LEU LEU ASN VAL LYS PRO ILE GLU SEQRES 17 B 278 ASP ILE GLN ASP ASN LEU LEU GLN ALA LEU GLU LEU GLN SEQRES 18 B 278 LEU LYS LEU ASN HIS PRO GLU SER SER GLN LEU PHE ALA SEQRES 19 B 278 LYS LEU LEU GLN LYS MET THR ASP LEU ARG GLN ILE VAL SEQRES 20 B 278 THR GLU HIS VAL GLN LEU LEU GLN VAL ILE LYS LYS THR SEQRES 21 B 278 GLU THR ASP MET SER LEU HIS PRO LEU LEU GLN GLU ILE SEQRES 22 B 278 TYR LYS ASP LEU TYR HET KNA A 1 11 HET KNA A 2 11 HET LU2 B 1 21 HET MYR B 478 16 HETNAM KNA NONANOIC ACID HETNAM LU2 2-(3,4-DIHYDROXYPHENYL)-5,7-DIHYDROXY-4H-CHROMEN-4-ONE HETNAM MYR MYRISTIC ACID HETSYN LU2 LUTEOLIN FORMUL 3 KNA 2(C9 H18 O2) FORMUL 5 LU2 C15 H10 O6 FORMUL 6 MYR C14 H28 O2 FORMUL 7 HOH *98(H2 O) HELIX 1 1 GLU A 207 PHE A 226 1 20 HELIX 2 2 THR A 229 THR A 238 1 10 HELIX 3 3 ASP A 251 ILE A 262 1 12 HELIX 4 4 GLU A 276 SER A 302 1 27 HELIX 5 5 GLY A 305 LEU A 309 5 5 HELIX 6 6 ASP A 310 LEU A 333 1 24 HELIX 7 7 ARG A 350 SER A 355 1 6 HELIX 8 8 PRO A 359 PHE A 363 5 5 HELIX 9 9 MET A 364 ALA A 376 1 13 HELIX 10 10 ASP A 380 LEU A 393 1 14 HELIX 11 11 ASN A 402 HIS A 425 1 24 HELIX 12 12 GLN A 430 GLU A 460 1 31 HELIX 13 13 HIS A 466 LYS A 474 1 9 HELIX 14 14 GLU B 207 PHE B 226 1 20 HELIX 15 15 THR B 229 GLY B 239 1 11 HELIX 16 16 ASP B 251 ILE B 262 1 12 HELIX 17 17 GLU B 276 SER B 302 1 27 HELIX 18 18 GLY B 305 LEU B 309 5 5 HELIX 19 19 ASP B 310 LEU B 333 1 24 HELIX 20 20 ARG B 350 SER B 355 1 6 HELIX 21 21 PRO B 359 PHE B 363 5 5 HELIX 22 22 MET B 364 ALA B 376 1 13 HELIX 23 23 ASP B 380 LEU B 393 1 14 HELIX 24 24 ASN B 402 HIS B 425 1 24 HELIX 25 25 GLN B 430 GLU B 460 1 31 HELIX 26 26 HIS B 466 TYR B 473 1 8 SHEET 1 A 3 PHE A 247 ILE A 249 0 SHEET 2 A 3 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 A 3 GLY A 338 ILE A 341 -1 N VAL A 339 O MET A 348 SHEET 1 B 3 PHE B 247 ILE B 249 0 SHEET 2 B 3 GLY B 346 THR B 349 1 O PHE B 347 N ILE B 249 SHEET 3 B 3 GLY B 338 ILE B 341 -1 N VAL B 339 O MET B 348 CISPEP 1 LYS A 358 PRO A 359 0 5.32 CISPEP 2 LYS A 474 ASP A 475 0 2.76 CISPEP 3 LYS B 358 PRO B 359 0 0.47 SITE 1 AC1 6 GLU A 259 ILE A 281 GLY A 284 ARG A 288 SITE 2 AC1 6 ILE A 341 SER A 342 SITE 1 AC2 8 CYS A 285 ARG A 288 SER A 289 ALA A 292 SITE 2 AC2 8 GLU A 295 ILE A 326 MET A 329 LEU A 330 SITE 1 AC3 12 HOH B 15 HOH B 94 PHE B 264 LYS B 265 SITE 2 AC3 12 HIS B 266 GLY B 284 CYS B 285 PHE B 287 SITE 3 AC3 12 ARG B 288 LEU B 330 MET B 364 MYR B 478 SITE 1 AC4 8 LU2 B 1 HOH B 94 ARG B 288 SER B 289 SITE 2 AC4 8 LEU B 333 PHE B 363 MET B 364 HIS B 449 CRYST1 92.260 62.150 119.130 90.00 101.67 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010839 0.000000 0.002239 0.00000 SCALE2 0.000000 0.016090 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008571 0.00000